Similarly, among the therapies for prostate cancer, the use of androgen receptor antagonists or modulators is prominent in the treatment of this pathology, but unfortunately, many cancers develop drug resistance, hampering the effectiveness of the therapy. The gene discussed is AR; the disease is prostate carcinoma.